Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 62,472 bioRxiv papers from 277,337 authors.

NADH as a cancer medicine

By Michael D Forrest

Posted 13 May 2015
bioRxiv DOI: 10.1101/019307

We propose that NADH will exert a specific kill action against some cancers. NADH is a natural metabolite. We envisage a low side effect profile and that NADH therapy will, additionally, combat the wastage and weakness of cancer patients, which can be the cause of death in some cases. Significantly, NADH can be administered orally and has already cleared clinical trials, all be it for other pathologies.

Download data

  • Downloaded 4,843 times
  • Download rankings, all-time:
    • Site-wide: 425 out of 62,482
    • In cancer biology: 13 out of 2,055
  • Year to date:
    • Site-wide: 2,313 out of 62,482
  • Since beginning of last month:
    • Site-wide: 4,107 out of 62,482

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide

Sign up for the Rxivist weekly newsletter! (Click here for more details.)